Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Label and Date Injectable Medications

Fremont, Ohio Survey Completed on 09-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that the facility failed to ensure proper labeling and dating of injectable medications for two residents who were prescribed injectable medications and resided on the 100-hall. During an inspection of the medication storage cart with an LPN, a Lantus SoloStar Pen containing insulin glargine was found with approximately 60 units remaining, but it was not labeled with the date it was opened or its expiration date. The LPN confirmed at the time of observation that the pen was missing these required labels. According to the medication supplier guidelines, Lantus insulin pens expire 28 days after first use or removal from refrigeration. Additionally, two Ozempic (semaglutide) pens were found in the same medication cart, both lacking labels indicating the resident's name, the date opened, or the expiration date, despite being labeled by the manufacturer for single patient use only. The LPN confirmed that neither pen was labeled appropriately. Facility policy and supplier guidelines require that medications with shortened expiration dates, such as these injectables, be labeled with the date opened and the new expiration date to ensure medication purity and potency. The failure to follow these procedures resulted in the cited deficiency.

An unhandled error has occurred. Reload 🗙